Emotional Function News Today

ABBVie today announced that the New England Journal of Medicine  has published 12-week results from the Phase 3 ADVANCE trial evaluating atogepant for the preventive treatment of migraine in adults who meet criteria for episodic migraine. The study, which enrolled adult participants experiencing 4 to 14 migraine days per month, found that all active treatment arms of atogepant 10 mg, 30 mg, and 60 mg once-daily ...

Heart Survivors Regain Their Quality Of Life Via Meditation by Karishma Abhishek on  March 14, 2021 at 7:08 AM Quality of life can be improved in heart attack patients along with the reduction in fear of activity with the aid of an eight-week program of mindfulness meditation, as per research at ESC Acute Cardiovascular Care 2021, an online scientific congress of the European Society of Cardiology (ESC).1 "A heart attack is a serious life-threatening event and survivors c...